Treatment with olaparib monotherapy in the maintenance setting significantly improves progression-free survival in patients with platinum-sensitive relapsed ovarian cancer: Results from the phase III SOLO2 study

Saved in:
Bibliographic Details
Published in:Gynecologic oncology 2017-06, Vol.145, p.219-220
Main Authors: Pujade-Lauraine, E, Ledermann, J.A, Penson, R.T, Oza, A.M, Korach, J, Huzarski, T, Poveda, A, Pignata, S, Friedlander, M, Colombo, N
Format: Article
Language:English
Subjects:
Hematology, Oncology and Palliative Medicine
Obstetrics and Gynecology
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0090-8258
DOI:10.1016/j.ygyno.2017.03.505